sábado, 19 de abril de 2025

Five priorities to remake the FDA in a time of deep uncertainty As former FDA leaders, we see opportunities for success — if the commissioner avoids political interference

https://www.statnews.com/2025/04/18/fda-marty-makary-biotech-industry-review-teams-mission-product-evaluation/

No hay comentarios: